Nephrology

University of Washington

University of Washington tumor board

Questions discussed in this category

Is there still a role for plasma exchange/PLEX for confirmed or suspected cast nephropathy in multiple myeloma to rapidly reduce light chain burden?

In addition to reversing hypercalcemia, initiating myeloma therapy, etc.

1 Answer available

Papers discussed in this category

Journal of the American Society of Nephrology : JASN, 2007-03

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

Lancet Haematol, 2019 Mar 11

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.

Related Topics in Nephrology